Keywords: Europe, EMA, CHMP, Boehringer Ingelheim, Lilly, Tradjenta, Novartis, Votubia, Sigma Tau, Eurartesim, Takeda, Actos, Pioglitazone

EMA recommends Boehringer/Lilly’s Tradjenta, Novartis’ Votubia and Sigma-Tau’s Eurartesim; updates on pioglitazone

Article | 27 June 2011

Print This

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) on Friday recommending approval of German ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in